BlogPerspectives
covid-19 vaccine handling

COVID-19 vaccine handling: Maximizing doses and public confidence

Share
By: By Debbie Hatmaker, PhD, RN, FAAN, and Nurisha Wade

The American Nurses Association (ANA) is proud of the leading role nurses play at all levels of the coronavirus pandemic that has shaken the world and transformed care delivery. Nurses have been the backbone of COVID-19 care and prevention, and key educators of patients and the public on how to slow the spread, so we can return to some semblance of normalcy. As the voice of 4.2 million registered nurses, ANA has reached into the nursing community with vital information and tools, and together we cheered on December 14, 2020, when a nurse was the first to receive a COVID-19 vaccine—an event seen by millions on national television.

The ongoing expansion of COVID-19 vaccination efforts, options, and programs nationwide requires nursing professionals’ full engagement, leadership, and continuous learning. The current landscape of nurses delivering care while promoting wellness during a public health crisis demands adaptability, resilience, and perseverance. As members of the most trusted profession, we embrace our critical role to help ensure quality and public trust in available vaccines. One tool that can help nurses accomplish this is the COVID-19 Vaccine Handling Toolkit from the U.S. Pharmacopeia (USP).

Meeting challenges head on

USP’s COVID-19 Vaccine Handling Toolkit is designed to help address the challenges nurses and other healthcare providers face every day in preparing, distributing and administering essential vaccines. Simply put, the toolkit outlines strategies and resources to achieve operational efficiencies that maximize vaccinations, minimize potential waste, ensure confidence in essential processes, and increase public trust in vaccine quality. Available online, the toolkit is updated regularly to keep pace with changes in scientific knowledge and best practices.

To help achieve these goals, ANA is working with USP to disseminate the COVID-19 Vaccine Handling Toolkit throughout the nursing community and across the healthcare ecosystem. We invite you to join us in using and sharing the toolkit across your practice setting to help advance our shared commitment to ending the pandemic as quickly as possible.

Supporting safety and accelerated delivery  

The COVID-19 Vaccine Handling Toolkit aims to facilitate consistency in vaccine handling practices. It can help provide confidence among nurses and other healthcare practitioners that they are helping to ensure the quality of the vaccine for patients, while also following the latest safe-handling practices to protect themselves. Broad implementation of toolkit strategies will also help boost public confidence in vaccination as an essential part of the solution to the pandemic and appropriate preventive care – especially for those most vulnerable. 

Convening diverse stakeholders

The toolkit was developed by over 30 independent expert volunteers led by USP’s Healthcare Safety and Quality Expert Committee with representation from several other Expert Committees, including U.S. government representatives from the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration. The toolkit is being updated periodically as new information and vaccines become available. Users should register to receive updates at www.usp.org/covid-vaccine-handling. 

Building essential resources

Beyond the toolkit, ANA and USP are working together to share evidence-based information to help healthcare practitioners and their patients learn more about COVID-19 vaccines and build public trust.

For over 200 years, USP has worked to build trust where it matters most: in the world’s medicines, dietary supplements and foods. To learn more about USP’s standards for quality vaccines and other COVID-19 response efforts, including USP’s Hand Sanitizer Toolkit, visit www.usp.org/COVID-19. For more on ANA’s response efforts, click here.

Debbie Hatmaker is executive vice president and chief nursing officer of the ANA Enterprise. Nurisha Wade is vice president of the Global Healthcare Quality and Safety Center of Excellence at USP.

*Online Bonus Content: These are opinion pieces and are not peer reviewed. The views and opinions expressed by Perspectives contributors are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.


cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Test Your Knowledge

Which of the following patients is at the highest risk for developing autonomic dysreflexia (AD)?

More Perspectives